Skip to content

Addiction: all studies

Page 713 of 863: studies 7,121 to 7,130 of 8,627, newest first. Back to the addiction overview

Research

Activation of the occipital cortex and deactivation of the default mode network during working memory in the early blind.

Journal of the International Neuropsychological Society May 2011 Hae-Jeong Park, Ji-Won Chun, Bumhee Park et al.

Although blind people heavily depend on working memory to manage daily life without visual information, it is not clear yet whether their working memory processing involves functional reorganization of the memory-related cortical network. To explore functional reorganization of the cortical network that supports various types of working memory processes in the early blind, we investigated...

Human Ecstasy use is associated with increased cortical excitability: an fMRI study.

Neuropsychopharmacology May 2011 Amy L Bauernfeind, Mary S Dietrich, Jennifer U Blackford et al.

The serotonergic neurotoxin, 3,4-methylenedioxymethamphetamine (MDMA/Ecstasy), is a highly popular recreational drug. Human recreational MDMA users have neurocognitive and neuropsychiatric impairments, and human neuroimaging data are consistent with animal reports of serotonin neurotoxicity. However, functional neuroimaging studies have not found consistent effects of MDMA on brain...

Mindfulness-based cognitive therapy: culture clash or creative fusion?

Contemporary Buddhism May 1, 2011 Melanie Fennell, Zindel V. Segal 31 citations

AbstractMindfulness-based cognitive therapy creates an unlikely partnership, between the ancient tradition of mindfulness meditation rooted in Buddhist thought, and the much more recent and essentially western tradition of cognitive and clinical science. This article investigates points of congruence and difference between the two traditions and concludes that, despite first appearances, this...

Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.

Drug and Alcohol Dependence May 1, 2011 Matthew W Johnson, Katherine A Maclean, Chad J Reissig et al. 134 citations

Salvinorin A is a potent, selective nonnitrogenous kappa opioid agonist and the known psychoactive constituent of Salvia divinorum, a member of the mint family that has been used for centuries by Mazatec shamans of Mexico for divination and spiritual healing. S. divinorum has over the last several years gained increased popularity as a recreational drug. This is a double-blind, placebo...

The Perceptual View of Pain: An Urgent Question in the Philosophy of Mind

April 29, 2011 A. Monteiro

The aim of this chapter is to present the state of the art of the philosophical debates about pain and demonstrate its importance in the current Philosophy of Mind; my contention is that it is an important point of convergence between the research done in cognitive sciences and philosophical thought. The central point of discussion is whether pain is a form of perception, in the sense that it...

Multisensory mechanisms in temporo-parietal cortex support self-location and first-person perspective.

Neuron April 28, 2011 Silvio Ionta, Lukas Heydrich, Bigna Lenggenhager et al.

Self-consciousness has mostly been approached by philosophical enquiry and not by empirical neuroscientific study, leading to an overabundance of diverging theories and an absence of data-driven theories. Using robotic technology, we achieved specific bodily conflicts and induced predictable changes in a fundamental aspect of self-consciousness by altering where healthy subjects experienced...

Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination

Drug Testing and Analysis April 28, 2011 Joanne C Lin, Reem Kais Jan, Robert R. Kydd et al. 70 citations

The use of piperazine derivatives, colloquially named 'party pills', has been escalating in New Zealand and worldwide since their introduction in the 1990s. Benzylpiperazine (BZP) is often used alone, or can be combined with trifluoromethylphenylpiperazine (TFMPP). Taken together as an oral dose, they have been reported to produce effects similar to 3, 4-methylenedioxymethamphetamine (MDMA)....

Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3-4, methylenedioxymethamphetamine (MDMA) in female SD rats

European Journal of Pharmacology April 28, 2011 Pamela B. Yang, Kristal D. Atkins, Nachum Dafny 42 citations

The psychostimulants amphetamine and methylphenidate (MPD / Ritalin) are the drugs most often used to treat attention deficit hyperactivity disorder (ADHD). In addition, students of all ages take these drugs to improve academic performance but also abuse them for pleasurable enhancement. In addition, other psychostimulants such 3,4 methylenedioxymethamphetamine (MDMA / ecstasy) are used /...

Pro‐oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes

British Journal of Pharmacology April 21, 2011 Daniel José Barbosa, João Paulo Capela, Jorge M.A. Oliveira et al. 60 citations

BACKGROUND AND PURPOSE: 3,4-Methylenedioxymethamphetamine (MDMA or 'Ecstasy') is a worldwide major drug of abuse known to elicit neurotoxic effects. The mechanisms underlying the neurotoxic effects of MDMA are not clear at present, but the metabolism of dopamine and 5-HT by monoamine oxidase (MAO), as well as the hepatic biotransformation of MDMA into pro-oxidant reactive metabolites is thought...

The self: From philosophy to cognitive neuroscience

Neurocase April 18, 2011 Winston Chiong 12 citations

Neuroscientists have recently begun to explore topics, such as the nature of the self, that were previously considered problems for philosophy rather than for science. This article aims to provide a starting point for interdisciplinary exchange by reviewing three philosophical debates about the nature of the self in light of contemporary work in cognitive neuroscience. Continental rationalist...